Table 3.

Hypertension status stratified analyses of abnormal lipid indices and the risk of IS.

Lipid indices	Group	Non-hypertension		Hypertension		${\text{P}}_{\text{heterogeneity}}^{\text{b}}$
		HR (95% CI)a	P a	HR (95% CI)a	P a
TC	<240 mg/dl	reference	-	reference	-
	≥240 mg/dl	0.445 (0.176–1.123)	0.086	1.224 (0.801–1.868)	0.350	0.052
TG	<200 mg/dl	reference	-	reference	-
	≥200 mg/dl	0.714 (0.373–1.368)	0.310	1.254 (0.891–1.765)	0.194	0.133
HDL-C	40–60mg/dl	reference	-	reference	-
	<40 mg/dl	0.884 (0.477–1.639)	0.695	1.157 (0.778–1.720)	0.471	0.472
	>60 mg/dl	1.411 (0.883–2.253)	0.150	0.665 (0.450–0.983)	0.041	0.016
LDL-C	<160 mg/dl	reference	-	reference	-
	≥160 mg/dl	0.401 (0.056–2.880)	0.364	1.000 (0.542–1.847)	0.999	0.385
Non-HDL-C	<190 mg/dl	reference	-	reference	-
	≥190 mg/dl	0.319 (0.098–1.036)	0.057	1.565 (1.007–2.429)	0.046	0.013
RC	<30 mg/dl	reference	-	reference	-
	≥30 mg/dl	0.749 (0.488–1.148)	0.184	1.071 (0.795–1.442)	0.651	0.179
TC/HDL-C	<3.6	reference	-	reference	-
	≥3.6	0.479 (0.307–0.750)	0.001	1.303 (0.955–1.778)	0.094	<0.001
TG/HDL-C	<1	reference	-	reference	-
	≥1	0.698 (0.447–1.090)	0.114	1.259 (0.925–1.714)	0.143	0.033
LDL-C/HDL-C	<2	reference	-	reference	-
	≥2	0.800 (0.523–1.223)	0.302	1.414 (1.034–1.933)	0.030	0.126

TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Non-HDL-C, non-high-density lipoprotein cholesterol; RC, remnant cholesterol.

^a: Adjusted for age, gender, BMI, cigarette smoking, alcohol consumption, T2DM at baseline, and use of lipid-lowering drugs.

^b: P_{heterogeneity} stands for the P value of the heterogeneity test.